Reference
Dupilumab (Dupixent?): risk of ocular adverse reactions and need for prompt management Internet Document : 9 Dec 2022. Available from: URL: https://www.gov.uk/drug-safety-update/dupilumab-dupixentv-risk-of-ocular-adverse-reactions-and-need-for-prompt-management
Rights and permissions
About this article
Cite this article
Dupilumab- and tralokinumab-related eye disorders. Reactions Weekly 1937, 4 (2022). https://doi.org/10.1007/s40278-022-29684-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-29684-1